NCT00320502View on ClinicalTrials.gov

A Phase 2 Study to Determine the Effects of BXT-51072 in Diabetic Patients Undergoing Angioplasty (PCI)

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

March 31, 2008

Study Completion Date

August 31, 2008

Conditions
Acute Coronary SyndromeType 2 Diabetes
Interventions
DRUG

BXT-51072

Trial Locations (4)

13100

Rivka Sieff Hospital, Safed

22100

Western Galilee Hospital, Nahariya

31096

Rambam Medical Center, Haifa

64239

Sourasky Medical Center, Tel Aviv

All Listed Sponsors
lead

Synvista Therapeutics, Inc

INDUSTRY

NCT00320502 - A Phase 2 Study to Determine the Effects of BXT-51072 in Diabetic Patients Undergoing Angioplasty (PCI) | Biotech Hunter | Biotech Hunter